Joincare Pharmaceutical Group Industry Co Ltd (600380) — Financial Flexibility Index
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥1.25 Billion (operating CF CN¥1.09 Billion minus capex CN¥155.85 Million) represents 0% of total liabilities (CN¥11.93 Billion). Also explore Joincare Pharmaceutical Group Industry C net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Joincare Pharmaceutical Group Industry Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Check strategic asset allocation of Joincare Pharmaceutical Group Industry C to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Joincare Pharmaceutical Group Industry Co Ltd. For the full company profile including market capitalisation, see 600380 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥4.66 Billion | CN¥3.89 Billion | CN¥11.05 Billion | ▲ +12.6% |
| 2024 | 0.37x | CN¥4.62 Billion | CN¥3.64 Billion | CN¥12.32 Billion | ▲ +1.6% |
| 2023 | 0.37x | CN¥5.06 Billion | CN¥3.93 Billion | CN¥13.72 Billion | ▼ -1.4% |
| 2022 | 0.37x | CN¥5.13 Billion | CN¥3.98 Billion | CN¥13.71 Billion | ▼ 0.0% |
| 2021 | 0.37x | CN¥4.08 Billion | CN¥2.56 Billion | CN¥10.92 Billion | ▼ -13.5% |
| 2020 | 0.43x | CN¥3.86 Billion | CN¥3.02 Billion | CN¥8.92 Billion | ▲ +15.4% |
| 2019 | 0.37x | CN¥3.02 Billion | CN¥2.31 Billion | CN¥8.05 Billion | ▲ +31.2% |
| 2018 | 0.29x | CN¥2.48 Billion | CN¥1.83 Billion | CN¥8.69 Billion | ▲ +4.4% |
| 2017 | 0.27x | CN¥2.35 Billion | CN¥1.87 Billion | CN¥8.59 Billion | ▼ -14.1% |
| 2016 | 0.32x | CN¥2.14 Billion | CN¥1.64 Billion | CN¥6.74 Billion | ▲ +11.1% |
| 2015 | 0.29x | CN¥1.86 Billion | CN¥1.26 Billion | CN¥6.49 Billion | ▼ -11.6% |
| 2014 | 0.32x | CN¥1.80 Billion | CN¥979.46 Million | CN¥5.54 Billion | ▼ -5.5% |
| 2013 | 0.34x | CN¥1.62 Billion | CN¥635.52 Million | CN¥4.72 Billion | ▼ -10.6% |
| 2012 | 0.38x | CN¥1.60 Billion | CN¥734.36 Million | CN¥4.16 Billion | ▲ +18.1% |
| 2011 | 0.33x | CN¥1.09 Billion | CN¥650.36 Million | CN¥3.35 Billion | ▼ -65.6% |
| 2010 | 0.94x | CN¥1.69 Billion | CN¥1.11 Billion | CN¥1.79 Billion | ▲ +80.4% |
| 2009 | 0.52x | CN¥912.53 Million | CN¥605.66 Million | CN¥1.74 Billion | ▲ +52.4% |
| 2008 | 0.34x | CN¥672.72 Million | CN¥455.01 Million | CN¥1.96 Billion | ▼ -1.3% |
| 2007 | 0.35x | CN¥675.89 Million | CN¥429.26 Million | CN¥1.94 Billion | ▼ -15.0% |
| 2006 | 0.41x | CN¥762.69 Million | CN¥272.50 Million | CN¥1.86 Billion | ▼ -23.6% |
| 2005 | 0.54x | CN¥730.86 Million | CN¥363.13 Million | CN¥1.36 Billion | ▲ +67.3% |
| 2004 | 0.32x | CN¥461.61 Million | CN¥241.71 Million | CN¥1.44 Billion | ▲ +56.7% |
| 2003 | 0.20x | CN¥282.85 Million | CN¥172.25 Million | CN¥1.38 Billion | ▼ -68.1% |
| 2002 | 0.64x | CN¥328.22 Million | CN¥236.13 Million | CN¥511.40 Million | ▼ -24.3% |
| 2001 | 0.85x | CN¥293.34 Million | CN¥223.79 Million | CN¥346.20 Million | ▲ +76.4% |
| 2000 | 0.48x | CN¥241.07 Million | CN¥171.61 Million | CN¥501.77 Million | ▲ +48.7% |
| 1999 | 0.32x | CN¥158.97 Million | CN¥109.82 Million | CN¥492.14 Million | — |